Suppr超能文献

磺胺嘧啶和甲氧苄啶在人体中的药代动力学。

Pharmacokinetics of sulfadiazine and trimethoprim in man.

作者信息

Andreasen F, Elsborg L, Husted S, Thomsen O

出版信息

Eur J Clin Pharmacol. 1978 Nov 9;14(1):57-67. doi: 10.1007/BF00560259.

Abstract

Sulfadiazine (SDZ) 800 mg and trimethoprim (TMP) 160 mg were given orally to 10 normal subjects and the concentration of SDZ and TMP in serum and urine was followed for 24 h. Both drugs showed a significant negative correlation between individual "peak" concentrations in serum and the body weight of the subject. Twelve hours after dosing the serum concentration was 12 to 25 microgram/ml for SDZ and 0.3 to 1.1 microgram/ml for TMP. Individual concentration ratios between SDZ and TMP in serum were 4.8 (1 h)--145 (24 h), and in the urine the ratio was close to 6 throughout the 24 h collection period. The range of urinary concentrations was from 65 to 400 microgram/ml for SDZ and from 13.8 to 93.4 microgram/ml for TMP. The fraction (formula: see text) was 21% during the 0--8 h period, 33% during the 8--15 h period and 41% during the 15--24 period. The average "t1/2" was 15.2 +/- 7.4 h for SDZ and 7.4 +/- 1.9 h for TMP. Individual subjects showed a significant correlation between the serum clearance of TMP and SDZ (p less than 0.01) and also between the renal clearance of the two drugs (p less than 0.05). The serum clearance was significantly correlated with the renal clearance for TMP but not for SDZ. For SDZ Vd was significantly negatively correlated with the elimination constant; for TMP no such correlation was found. The serum clearance of SDZ was significantly correlated with the percentage of SDZ which was excreted as the (presumably) acetylated compound. The renal clearance of SDZ was independent of the serum concentration of SDZ. There was a highly significant negative correlation between the renal clearance and serum concentration of TMP, as well as for "acetylated SDZ". The renal clearance of "acetylated SDZ" averaged more than six times that of unconjugated SDZ. With increased urine flow the renal clearances of TMP and SDZ were significantly increased.

摘要

给10名正常受试者口服800毫克磺胺嘧啶(SDZ)和160毫克甲氧苄啶(TMP),并对血清和尿液中SDZ和TMP的浓度进行24小时监测。两种药物在血清中的个体“峰值”浓度与受试者体重之间均呈现显著负相关。给药12小时后,SDZ的血清浓度为12至25微克/毫升,TMP的血清浓度为0.3至1.1微克/毫升。血清中SDZ与TMP的个体浓度比为4.8(1小时)至145(24小时),在整个24小时收集期内,尿液中的比值接近6。SDZ的尿液浓度范围为65至400微克/毫升,TMP的尿液浓度范围为13.8至93.4微克/毫升。0至8小时期间的分数(公式:见正文)为21%,8至15小时期间为33%,15至24小时期间为41%。SDZ的平均“t1/2”为15.2±7.4小时,TMP的平均“t1/2”为7.4±1.9小时。个体受试者中,TMP与SDZ的血清清除率之间存在显著相关性(p<0.01),两种药物的肾清除率之间也存在显著相关性(p<0.05)。TMP的血清清除率与肾清除率显著相关,但SDZ并非如此。对于SDZ,Vd与消除常数显著负相关;对于TMP,未发现此类相关性。SDZ的血清清除率与以(可能)乙酰化化合物形式排泄的SDZ百分比显著相关。SDZ的肾清除率与SDZ的血清浓度无关。TMP以及“乙酰化SDZ”的肾清除率与血清浓度之间存在高度显著的负相关。“乙酰化SDZ”的肾清除率平均是未结合SDZ的六倍多。随着尿流量增加,TMP和SDZ的肾清除率显著增加。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验